Delivery Order SPE2DB20D1100-SPE2DB25FE3M9
Award Date 8/28/25
Potential Completion Date 8/29/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,227.66 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose 10s) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract reflects a routine pharmaceutical procurement through the agency's medical supply chain. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of UBRELVY 100 mg tablet unit dose packages (10 count). This competitively awarded, non-set-aside contract carries a ceiling value of $3,712.21 with a firm fixed price structure and an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $2,051.65 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose) on September 8, 2025, with completion scheduled for September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9,481.53 for UBRELVY 100 mg tablets (16 unit dose packages) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.44 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10-count unit dose packaging) on September 19, 2025, with completion expected by September 22, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $18,890.27 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10 unit-dose packs). This competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (16 count). The contract, valued at $12,694.80, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award authority. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $6,244.42 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablet unit dose packages (16 count) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's pharmaceutical supply support to federal military and healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $4,613.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose, 10 count) on May 7, 2025, with an ultimate completion date of May 8, 2025. This non-set-aside award represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $2,201.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose packs) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...